Patients taking anticoagulant medications (such as warfarin or apixaban) or antiplatelet agents (like aspirin or clopidogrel) experience impaired clotting mechanisms, significantly increasing bruising risk
While this poses challenges for manufacturers, it also creates novel opportunities for innovation in product development, marketing, and nutrition-focused products
[1] In the SUSTAIN clinical trial programme , which evaluated semaglutide's efficacy and safety in thousands of patients with type 2 diabetes, anxiety was not reported as a statistically significant adverse event compared to placebo or active comparators
Up to 24.2% body weight reduction after 48 weeks has been observed with higher doses in people with obesity
The FDA has flagged compounders using semaglutide sodium and semaglutide acetate, which are different active ingredients from the approved product, and states it lacks information on whether those salts share the same chemical and pharmacologic properties
Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis